Deal Snapshot
PROXY ADVISORS ISS AND GLASS LEWIS RECOMMEND FLEX PHARMA SHAREHOLDERS SUPPORT MERGER
Tuesday 11 June 2019

US-based proxy advisors Institutional Shareholder Services Inc. and Glass Lewis recommend that shareholders of Boston, US-based biotechnology company Flex Pharma, Inc. (NASDAQ: FLKS) vote in favour of all agenda items before or at Flex Pharma's June 14 special shareholders meeting, the company said.
Flex's board of directors also unanimously recommends voting "For" all agenda items as the best way to preserve future shareholder value. ISS and Glass Lewis are US institutional voting advisory services. Salarius Pharmaceuticals, LLC, is a privately held clinical-stage oncology company targeting the epigenetic causes of cancers.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 11/06/2019
Target: Flex Pharma, Inc
Country: USA
Deal Size: 30m (USD)
Sector: Biotechnology
Type: Corporate acquisition
Financing: Stock
Status: Agreed
Vendor:
Buyer: Salarius Pharmaceuticals
Buyer Advisor: Healthios Capital Markets , Pillsbury Winthrop Shaw Pittman
Comment:
Terms of the deal were not disclosed

Options